{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:27:51Z","timestamp":1788449271785,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Our purpose was to evaluate the prognostic value of Vesical Imaging Reporting and Data System (VI-RADS) in bladder cancer (BCa) staging and predicting recurrence or progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed the prospectively collected data from 96 patients with bladder tumors who underwent VI-RADS-based multiparametric magnetic resonance imaging (mpMRI) before endourological treatment from April 2021 to December 2022. Diagnostic performance was evaluated by comparing mpMRI reports with final pathology, using logistic regression for muscle-invasive bladder cancer (MIBC) predictors. Follow-up until May 2023 included Kaplan-Meier and Cox regression analysis to assess VI-RADS predictive roles for recurrence-free survival (RFS) and progression-free survival (PFS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 96 patients (19.8% women, 80.2% men; median age 68.0 years) were included, with 71% having primary tumors and 29% recurrent BCa. Multiparametric MRI exhibited high sensitivity (92%) and specificity (79%) in predicting MIBC, showing no significant differences between primary and recurrent cancers (AUC: 0.96 vs. 0.92,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.565). VI-RADS emerged as a key predictor for MIBC in both univariate (OR: 40.3,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.001) and multivariate (OR: 54.6,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.001) analyses. Primary tumors with VI-RADS\u2009\u2265\u20093 demonstrated significantly shorter RFS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02) and PFS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In conclusion, mpMRI with VI-RADS has a high diagnostic value in predicting MIBC in both primary and recurrent BCa. A VI-RADS threshold\u2009\u2265\u20093 is a strong predictor for MIBC, and in primary tumors predicts early recurrence and progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-024-05101-2","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T08:05:30Z","timestamp":1721808330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of VI-RADS scoring criteria for predicting oncological outcomes in bladder cancer"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7533-4297","authenticated-orcid":false,"given":"Mieszko","family":"Kozikowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Zagrodzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Zawadzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Zugaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Osiecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciszek","family":"Rzymkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"\u015aled\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Sosnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Dobruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"5101_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"5101_CR2","unstructured":"Witjes JA, Bruins HM, Carri\u00f3n A, Cathomas R, Comp\u00e9rat EM, Efstathiou JA et al EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6"},{"key":"5101_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29047","author":"ME Charlton","year":"2014","unstructured":"Charlton ME, Adamo M, Sun L, Deorah S (2014) Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: a review of SEER data, 2004\u20132010. Cancer. https:\/\/doi.org\/10.1002\/cncr.29047","journal-title":"Cancer"},{"key":"5101_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.12.033","author":"RJ Sylvester","year":"2021","unstructured":"Sylvester RJ, Rodr\u00edguez O, Hern\u00e1ndez V, Turturica D, Bauerov\u00e1 L, Bruins HM et al (2021) European Association of Urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder Cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for Grade: an update from the EAU NMIBC guidelines Panel[Formula present. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2020.12.033","journal-title":"Eur Urol"},{"key":"5101_CR5","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017171028","author":"L Huang","year":"2018","unstructured":"Huang L, Kong Q, Liu Z, Wang J, Kang Z, Zhu Y (2018) The diagnostic value of MR imaging in differentiating t staging of bladder cancer: a meta-analysis. Radiology. https:\/\/doi.org\/10.1148\/radiol.2017171028","journal-title":"Radiology"},{"key":"5101_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.04.029","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S et al (2018) Multiparametric magnetic resonance imaging for bladder Cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2018.04.029","journal-title":"Eur Urol"},{"key":"5101_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.09.029","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G et al (2020) Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non\u2013muscle-invasive bladder Cancer patients candidate for repeated transurethral resection. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.029","journal-title":"Eur Urol"},{"key":"5101_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-022-03969-6","author":"F Del Giudice","year":"2022","unstructured":"Del Giudice F, Flammia RS, Pecoraro M, Moschini M, D\u2019Andrea D, Messina E et al (2022) The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations. World J Urol. https:\/\/doi.org\/10.1007\/s00345-022-03969-6","journal-title":"World J Urol"},{"key":"5101_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.02.021","author":"RT Bryan","year":"2021","unstructured":"Bryan RT, Liu W, Pirrie SJ, Amir R, Gallagher J, Hughes AI et al (2021) Comparing an imaging-guided pathway with the Standard Pathway for staging muscle-invasive bladder Cancer: Preliminary Data from the BladderPath Study[Formula presented]. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2021.02.021","journal-title":"Eur Urol"},{"key":"5101_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.04.007","author":"MMG Leeflang","year":"2009","unstructured":"Leeflang MMG, Bossuyt PMM, Irwig L (2009) Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. J Clin Epidemiol. https:\/\/doi.org\/10.1016\/j.jclinepi.2008.04.007","journal-title":"J Clin Epidemiol"},{"key":"5101_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-013-0038-0","author":"HJ Wang","year":"2014","unstructured":"Wang HJ, Pui MH, Guo Y, Yang D, Pan BT, Zhou XH (2014) Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection. Abdom Imaging. https:\/\/doi.org\/10.1007\/s00261-013-0038-0","journal-title":"Abdom Imaging"},{"key":"5101_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07765-5","author":"MI Metwally","year":"2021","unstructured":"Metwally MI, Zeed NA, Hamed EM, Elshetry ASF, Elfwakhry RM, Alaa Eldin AM et al (2021) The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-021-07765-5","journal-title":"Eur Radiol"},{"key":"5101_CR13","doi-asserted-by":"publisher","DOI":"10.1089\/end.2020.0301","author":"W Krajewski","year":"2020","unstructured":"Krajewski W, Nowak L, Poletajew S, Tukiendorf A, Moschini M, Mari A et al (2020) The impact of restaging transurethral resection of bladder tumor on survival parameters in T1 nonmuscle-invasive bladder Cancer: systematic review and Meta-analysis. J Endourol. https:\/\/doi.org\/10.1089\/end.2020.0301","journal-title":"J Endourol"},{"key":"5101_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02672-3","author":"H Liang","year":"2019","unstructured":"Liang H, Yang T, Wu K, He D, Fan J (2019) En Bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer. World J Urol. https:\/\/doi.org\/10.1007\/s00345-019-02672-3","journal-title":"World J Urol"},{"key":"5101_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2022.03.008","author":"TM El-Karamany","year":"2022","unstructured":"El-Karamany TM, Al-Adl AM, Hosny MM, Eldeep A, El-Hamshary H (2022) Clinical utility of vesical imaging-reporting and data system (VI-RADS) in non\u2009\u2013\u2009muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc transurethral resection: a prospective study. Urol Oncol Semin Orig Investig. https:\/\/doi.org\/10.1016\/j.urolonc.2022.03.008","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"5101_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235767","author":"R Nakagawa","year":"2022","unstructured":"Nakagawa R, Izumi K, Naito R, Kadomoto S, Iwamoto H, Yaegashi H et al (2022) Does bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT? Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14235767","journal-title":"Cancers (Basel)"},{"key":"5101_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/S0730-725X(00)00124-7","author":"W Saito","year":"2000","unstructured":"Saito W, Amanuma M, Tanaka J, Heshiki A (2000) Histopathological analysis of a bladder cancer stalk observed on MRI. Magn Reson Imaging. https:\/\/doi.org\/10.1016\/S0730-725X(00)00124-7","journal-title":"Magn Reson Imaging"},{"key":"5101_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.28924","author":"L Cai","year":"2023","unstructured":"Cai L, Yu R, Liu P, Zhuang J, Li K, Wu Q et al (2023) A Nomogram of MRI features to assess muscle Invasion in VI-RADS 2 tumors with stalk. J Magn Reson Imaging. https:\/\/doi.org\/10.1002\/jmri.28924","journal-title":"J Magn Reson Imaging"},{"key":"5101_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2021.05.005","author":"M Kozikowski","year":"2022","unstructured":"Kozikowski M, Suarez-Ibarrola R, Osiecki R, Bilski K, Gratzke C, Shariat SF et al (2022) Role of Radiomics in the prediction of muscle-invasive bladder Cancer: a systematic review and Meta-analysis. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2021.05.005","journal-title":"Eur Urol Focus"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05101-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-05101-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05101-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:05:25Z","timestamp":1768381525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-05101-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5101"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-05101-2","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"438"}}